Vietnam Stomach Cancer Treatment Market
Vietnam Stomach Cancer Treatment Market Size Set to Expand at Significant CAGR of 11.24% During 2023–2029
Published | 20 April 2023
Vietnam stomach cancer treatment market is gaining traction because of the robust product pipeline and increasing prevalence of the disease.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, expects the Vietnam stomach cancer treatment market size to grow at an impressive CAGR of 11.24% during the forecast period between 2023 and 2029. Changes in lifestyle, such as smoking and drinking, an increase in obesity, and a rise in gastric reflux syndrome are major growth factors for the Vietnam stomach cancer treatment market. In terms of malignancy-related mortality in both genders in Vietnam, colon and stomach cancer continue to rank third and ninth, respectively, according to epidemiological statistics. The Vietnam stomach cancer treatment market is expected to significantly expand over the forecast period due to rising healthcare accessibility.
Vietnam Stomach Cancer Treatment Market – Overview
The abnormal proliferation of malignant cells within the stomach lining is a symptom of stomach cancer. Until it spreads to other regions of the body, this form of cancer is typically difficult to identify in its early stages. Chemotherapy, radiation, and occasionally surgery can be used to treat symptoms and enhance the quality of life in stomach cancer situations when the disease cannot be fully cured. As long as all of the malignant tissue can be removed, surgery can treat stomach cancer if it is treatable.
Vietnam Stomach Cancer Treatment Market – By Drug Class
Based on drug class, the Vietnam stomach cancer treatment market is segmented into PD-1/PD-L1 inhibitors, HER2 antagonists, VEGFR2 antagonists, and others. Chemotherapy is the most prominent type of treatment for stomach cancer and is considered the first line of treatment for such a disease. Palliative chemotherapy for stomach cancer has been shown to prolong life and enhance the quality of life, according to research. Following chemotherapy, PD-1/PD-L1 inhibitors are projected to gain growth during the forecast period.
Impact of COVID-19 on Vietnam Stomach Cancer Treatment Market
The COVID-19 pandemic hindered the growth of the Vietnam stomach cancer treatment market. The increasing burden of the covid19 patients leads to a significant decline in non-COVID-19 patients' visits to healthcare facilities which resulted in delays in diagnosis and treatment. Due to greater hospital transmission rates, their frequent hospital visits would increase their chance of contracting COVID-19. As a result, chemotherapy patients faced a difficult choice: continuing treatment while raising their risk of infection or staying at home to put off starting their cancer therapies. Additionally, the pandemic had a big influence on stomach cancer clinical trials. The pandemic halted or delayed several research studies, which hampered the advancement of novel medications and treatments for the illness.
Major players operating in the Vietnam stomach cancer treatment market include Novartis AG, Pfizer, Inc., Mylan N.V., F. Hoffmann La Roche Ltd., Eli Lilly And Company, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Samsung Bioepis, and Otsuka Holdings Co. Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Vietnam Stomach Cancer Treatment Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Vietnam Stomach Cancer Treatment Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation from scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- Vietnam Stomach Cancer Treatment Market - By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery); By Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors); By Route of Administration (Oral, Injectable); By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others); By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Others); Trend Analysis, Competitive Landscape & Forecast, 2019–2029
Publish Date: April 2023
Robust product pipeline and increasing prevalence of the disease are expected to boost the growth of Vietnam stomach cancer market during the forecast period between 2023 and 2029.
Relevant Press Releases
- Global Cold Plasma Market flourishing at a CAGR of 18.3%: Expected to touch USD 5.8 billion by the year 2027
- Generic Drugs Market to Reach USD 745 Billion by 2028
- Global Disposable Catheters Market is Projected to Reach USD 15.0 Billion, Growing at a CAGR of 11.8% During 2021-2027
- Saudi Arabia Syringe Market to Grow at a CAGR of 12.4% during Forecast Period
- Saudi Arabia Medical Tourism Market to Grow at a CAGR of 4.6% during 2022 – 2028